Send feedback

ALDOA p.Arg123His

c.368G>A · rs752587498 · VCV2171117

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.2474 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00466%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
glycogen storage disease due to aldolase A deficiency

Computational evidence

Protein change
AlphaMissense0.2474likely benign
REVEL0.464indeterminate
SaProtLLR -9.84tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.6GERP 1.9, phastCons 1
Regional constrainto/e 0.91unconstrained · MANE · 3,311 bp · p 0.028 · regional, not allelic
Overall
CADD25.6PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R69H vs ClinVar R123H) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00466% European (non-Finnish) · 55/1,180,016 alleles
Filtering AF 0.00367% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00329%
Overall 0.00378% 61/1,613,664 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0048% 20,827
European (non-Finnish)grpmax 0.00466% 21,455
African / African-American 0.00267% 37,424
South Asian 0.0011% 91,080

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ALDOA
Protein
p.Arg123His
Coding
c.368G>A
MANE Select
NM_001243177
dbSNP
rs752587498
Type
single nucleotide variant
Location
chr16:30067543 (GRCh38)
Gene constraint
LOEUF 0.821 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 96.53 · 8 PDB
Residue 123
a β-strand
Full ALDOA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

glycogen storage disease due to aldolase A deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Glycogen storage disease due to aldolase A deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/aldoa-p-arg123his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown